Biotech International Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.48 Cr
as on 12-12-2024
- Company Age 31 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.10 Cr
as on 12-12-2024
- Satisfied Charges ₹ 7.90 Cr
as on 12-12-2024
- Revenue 1.44%
(FY 2022)
- Profit 27.09%
(FY 2022)
- Ebitda -30.34%
(FY 2022)
- Net Worth 32.62%
(FY 2022)
- Total Assets 5.79%
(FY 2022)
About Biotech International
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.48 Cr.
The company currently has active open charges totaling ₹42.10 Cr. The company has closed loans amounting to ₹7.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biotech International Limited India is Mr Singhal as CEO. Manjula Singhal, Saurabh Singhal, and Shahji Dhar serve as directors at the Company.
- CIN/LLPIN
U24297DL1993PLC052056
- Company No.
052056
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Feb 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biotech International Limited offer?
Biotech International Limited offers a wide range of products and services, including Insecticides and Pesticides, Bio Insecticides, Insecticides, Acaricide, Fertilizer, Bio Fertilizers, Bio Larvicide, Plant Growth Regulators, Gibberellic Acid, Biopesticides.
Who are the key members and board of directors at Biotech International?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Singhal  | Managing Director | 08-Feb-1993 | Current |
| Mr Singhal | CEO | 01-May-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manjula Singhal | Director | 25-Aug-1994 | Current |
| Shahji Dhar | Director | 27-Apr-2018 | Current |
Financial Performance and Corporate Structure Insights of Biotech International.
Biotech International Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.44% increase. The company also saw a substantial improvement in profitability, with a 27.09% increase in profit. The company's net worth Soared by an impressive increase of 32.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech International?
In 2022, Biotech International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemicals International Private LimitedActive 53 years 2 monthsManjula Singhal and Saurabh Singhal are mutual person
Computronics International LimitedActive 31 years 5 monthsManjula Singhal and Saurabh Singhal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Jun 2021 | ₹1.00 M | Open |
Canara Bank Creation Date: 29 Oct 2003 | ₹21.00 Cr | Open |
Canara Bank Creation Date: 26 Aug 1994 | ₹21.00 Cr | Open |
How Many Employees Work at Biotech International?
Biotech International has a workforce of 32 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
